Johnny Kao: Clinical Trials

2 trials sponsored by Johnny Kao, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 11Completed 1

Follow Johnny Kao: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer
erlotinib + celecoxib - Cancer of the Pharynx, Cancer of the Larynx
Phase 1 / Phase 2CompletedJohnny Kao152007-02-012017-04-10
Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer
Cetuximab, Hydroxyurea, Fluorouracil - Head and Neck Cancer, Cancer of the Pharynx
Phase 2CompletedJohnny Kao332007-02-012018-03-13

Conditions studied

Head and Neck Neoplasms (2)  ·  Laryngeal Neoplasms (2)  ·  Paranasal Sinus Neoplasms (2)  ·  Pharyngeal Neoplasms (2)  ·  Nose Neoplasms (1)

Interventions

Celecoxib (1)  ·  Cetuximab (1)  ·  Erlotinib Hydrochloride (1)  ·  Fluorouracil (1)  ·  Hydroxyurea (1)  ·  Radiotherapy (1)

Countries

United States (2)

Results publications

PMID 20830768, PMID 21246519